News

Quantum BioPharma Ltd. (NASDAQ: QNTM), a small biopharmaceutical company with an $8 million market cap, has launched a $700 million lawsuit against several of Wall Street’s largest financial ...
Short interest in Quantum BioPharma Ltd (NASDAQ:QNTM) decreased during the last reporting period, falling from 354.44K to 111.77K. This put 6.11% of the company's publicly available shares short.
Nasdaq-listed shares of Quantum BioPharma (QNTM) surged 15% on Wednesday after the companysaid its licensee, Celly Nutrition Corporation, has released a new format of its alcohol detox product ...
TORONTO, April 24, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) “Quantum BioPharma” or the “Company”), today ...
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...
Mr. Malone is a 2nd generation financial advisor with over 40 years of family experience in wealth management. This combined with his deep entrepreneurial background he launched Malone Wealth in 2021.
Once incredibly popular in the sneakerhead community, brand-new pairs of Adidas Yeezy QNTM Basketball Shoes are on sale now at Shoebacca for as low as $70. The list price of the sneakers is $250 ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
(MENAFN- Investor Brand Network) Quantum BioPharma (NASDAQ: QNTM) has announced that its licensee, Celly Nutrition Corporation, secured a strategic partnership with the Asian American Trade ...
Awards in favour of Quantum BioPharma Totalling $180,000 upheld and is now dueTORONTO, April 14, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream ...